Listen to their answers! Response behaviour in the measurement of physical and role functioning
- PMID: 18389384
- PMCID: PMC2358935
- DOI: 10.1007/s11136-008-9333-6
Listen to their answers! Response behaviour in the measurement of physical and role functioning
Abstract
Background: Quality of life (QoL) is considered to be an indispensable outcome measure of curative and palliative treatment. However, QoL research often yields findings that raise questions about what QoL measurement instruments actually assess and how the scores should be interpreted.
Objective: To investigate how patients interpret and respond to questions on the EORTC-QLQ-C30 over time and to find explanations to account for counterintuitive findings in QoL measurement.
Methods: Qualitative investigation was made of the response behaviour of small-cell lung cancer patients (n = 23) in the measurement of QoL with the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30). Focus was on physical functioning (PF, items 1 to 5), role functioning (RF, items 6 and 7), global health and QoL rating (GH/QOL, items 29 and 30). Interviews were held at four points: at the start of the chemotherapy, 4 weeks later, at the end, and 6 weeks after the end of chemotherapy. Patients were asked to 'think aloud' when filling in the questionnaire.
Results: Patients used various response strategies when answering questions about problems and limitations in functioning, which impacted the accuracy of the scale. Patients had scores suggesting they were less limited than they actually were by taking the wording of questions literally, by guessing their functioning in activities that they did not perform, and by ignoring or excluding certain activities that they could not perform.
Conclusion: Terminally ill patients evaluate their functioning in terms of what they perceive to be normal under the circumstances. Their answers can be interpreted in terms of change in the appraisal process (Rapkin and Schwartz 2004; Health and Quality of Life Outcomes, 2, 14). More care should be taken in assessing the quality of a set of questions about physical and role functioning.
Figures

Similar articles
-
Small-cell lung cancer patients are just 'a little bit' tired: response shift and self-presentation in the measurement of fatigue.Qual Life Res. 2007 Jun;16(5):853-61. doi: 10.1007/s11136-007-9178-4. Epub 2007 Feb 15. Qual Life Res. 2007. PMID: 17450423 Free PMC article.
-
Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.Oncology. 2008;74 Suppl 1:7-12. doi: 10.1159/000143212. Epub 2008 Aug 28. Oncology. 2008. PMID: 18758191
-
The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.Eur J Oncol Nurs. 2014 Aug;18(4):425-35. doi: 10.1016/j.ejon.2014.03.005. Epub 2014 Apr 8. Eur J Oncol Nurs. 2014. PMID: 24721179 Clinical Trial.
-
Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.Ann Oncol. 1998;9 Suppl 5:S147-54. doi: 10.1093/annonc/9.suppl_5.s147. Ann Oncol. 1998. PMID: 9926255 Review.
-
Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.BMC Cancer. 2021 Jan 27;21(1):99. doi: 10.1186/s12885-021-07793-w. BMC Cancer. 2021. PMID: 33499819 Free PMC article.
Cited by
-
How to Improve Interpretability of Patient-Reported Outcome Measures for Clinical Use: A Perspective on Measuring Abilities and Feelings.Patient Relat Outcome Meas. 2022 Mar 25;13:69-77. doi: 10.2147/PROM.S355679. eCollection 2022. Patient Relat Outcome Meas. 2022. PMID: 35370429 Free PMC article.
-
Choosing a patient-reported outcome measure.Theor Med Bioeth. 2011 Feb;32(1):47-60. doi: 10.1007/s11017-010-9163-8. Theor Med Bioeth. 2011. PMID: 21110121
-
Psychometric properties of two physical activity questionnaires, the AQuAA and the PASE, in cancer patients.BMC Med Res Methodol. 2011 Mar 16;11:30. doi: 10.1186/1471-2288-11-30. BMC Med Res Methodol. 2011. PMID: 21410979 Free PMC article.
-
Patient-reported outcome measures ( PROMs): making sense of individual PROM scores and changes in PROM scores over time.Nephrology (Carlton). 2021 May;26(5):391-399. doi: 10.1111/nep.13843. Epub 2020 Dec 25. Nephrology (Carlton). 2021. PMID: 33325638 Free PMC article. Review.
-
Exploration of the content validity and feasibility of the EQ-5D-3L, ICECAP-O and ASCOT in older adults.BMC Health Serv Res. 2015 May 15;15:201. doi: 10.1186/s12913-015-0862-8. BMC Health Serv Res. 2015. PMID: 25976227 Free PMC article.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '2776397', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/2776397/'}]}
- Llewellyn-Thomas, H. A., Thiel, E. C., & Clark, R. M. (1989). Patients versus surrogates: Whose opinion counts on the ethics review panels? Clinical Research, 37, 51–55. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/0895-4356(89)90085-1', 'is_inner': False, 'url': 'https://doi.org/10.1016/0895-4356(89)90085-1'}, {'type': 'PubMed', 'value': '2918321', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/2918321/'}]}
- O’Connor, A. M. (1989). Effects of framing and level of probability on patients’ preferences for cancer chemotherapy. Journal of Clinical Epidemiology, 42(2), 119–126. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/0959-8049(95)00513-7', 'is_inner': False, 'url': 'https://doi.org/10.1016/0959-8049(95)00513-7'}, {'type': 'PubMed', 'value': '8562147', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8562147/'}]}
- Bremnes, R. M., Andersen, K., & Wist, E. A. (1995). Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy. European Journal of Cancer, 31A, 1955–1959. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1663147', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1663147/'}, {'type': 'PubMed', 'value': '2379006', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/2379006/'}]}
- Slevin, M. L., Stubbs, L., Plant, H. J., Wilson, P., Gregory, W. M., & Armes, P. J., et al. (1990). Attitudes to chemotherapy: Comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ, 300, 1458–1460. - PMC - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1634/theoncologist.9-90006-14', 'is_inner': False, 'url': 'https://doi.org/10.1634/theoncologist.9-90006-14'}, {'type': 'PubMed', 'value': '15616146', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15616146/'}]}
- Gralla, R. J. (2004). Quality-of-life considerations in patients with advanced lung cancer: Effect of topotecan on symptom palliation and quality of life. Oncologist, 9(Suppl. 6), 14–24. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources